PillSeek

Reviewed by PillSeek Editorial Team · Last updated

Combivir

Lamivudine 150 mg;zidovudine 300 mg;

About This Medication

This medication is a White Oval 17 mm, Film coated tablet with imprint "GXFC3". It contains Lamivudine 150 mg;zidovudine 300 mg; of Lamivudine[lamivudine];zidovudine[zidovudine];. This belongs to the Human immunodeficiency virus nucleoside analog reverse transcriptase inhibitor pharmacologic class. It is manufactured by ViiV Healthcare Company. For details please contact your physician.

Basic Information

Imprint
GXFC3
Color
White
Shape
Oval
Size
17 mm

Drug Information

Strength
Lamivudine 150 mg;zidovudine 300 mg;
Dosage Form
Film coated tablet
RxCUI
213088

Related Medications

Other drugs in the same class: Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor

Ingredients

Active Ingredients
Lamivudine[lamivudine];zidovudine[zidovudine];
Inactive Ingredients
Silicon dioxide;hypromellose, unspecified;magnesium stearate;microcrystalline cellulose;polyethylene glycol, unspecified;polysorbate 80;sodium starch glycolate type a potato;titanium dioxide;

Additional Information

Manufacturer
ViiV Healthcare Company
Status (Rx/OTC)
Rx
Brand Names
Combivir

⚠️ Important: This information is for educational purposes only. Do not use this tool for medical diagnosis or treatment decisions. Always consult your pharmacist or healthcare provider for questions about your medications. Read full medical disclaimer.

White Oval Combivir Lamivudine 150 mg;zidovudine 300 mg; Pill With Imprint GXFC3 | PillSeek